BSTC - BioSpecifics Tech misses on revenue August, 09 2019 04:04 PM BioSpecifics Technologies Corp BioSpecifics Tech (NASDAQ:BSTC): Q2 GAAP EPS of $0.87.Revenue of $8.85M (+12.7% Y/Y) misses by $0.13M.Press ReleaseMore news on: BioSpecifics Technologies Corp., Earnings news and commentary, Healthcare stocks news,